Evidence map›Paper›PMID 33191759›Full record

ArticleAIDS care2021

High risk and low HIV prevention behaviours in a new generation of young trans women in Brazil.

Erin C Wilson, Emilia M Jalil, Ronaldo I Moreira, Luciane Velasque, Cristiane V Castro, Laylla Monteiro, Valdilea G Veloso, Beatriz Grinsztejn

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Mental Health Outcomes AmongInternational journal of environmental research and public health · 2025
    Review
  2. Article
  3. Article
  4. HIV prevention among adolescents travestis and transgender women in three Brazilian capitals, 2019-2023.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Erin C WilsonSan Francisco Department of Public Health, San Francisco, CA, USA.
Emilia M JalilInstituto Nacional de Infectologia Evandro Chagas (INI), Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Ronaldo I MoreiraInstituto Nacional de Infectologia Evandro Chagas (INI), Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Luciane VelasqueInstituto Nacional de Infectologia Evandro Chagas (INI), Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Cristiane V CastroInstituto Nacional de Infectologia Evandro Chagas (INI), Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Laylla MonteiroInstituto Nacional de Infectologia Evandro Chagas (INI), Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Valdilea G VelosoInstituto Nacional de Infectologia Evandro Chagas (INI), Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.ORCID 0000-0002-6622-3165
Beatriz GrinsztejnInstituto Nacional de Infectologia Evandro Chagas (INI), Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Instituto Evandro Chagas · BRSan Francisco Department of Public Health · US

Funding

San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)U01AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI GRINSZTEJN, BEATRIZ · 2008 to 2011
$14.0M
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNITU01AI048022 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI BUCHBINDER, SUSAN · 2000 to 2006
$8.7M
NIAID NIH HHS U01 AI048022NIAID NIH HHS U01 AI069476NIAID NIH HHS UM1 AI069476NIAID NIH HHS UM1 AI069496
6 · The paper itself

Abstract

Adult trans women in Brazil are highly impacted by HIV, but little is known about risk for young trans women. Our study was conducted to compare the HIV prevalence and correlates of risk for young trans women ages 18-24 years old to adult trans women in Brazil. Trans women were recruited from Rio de Janeiro and Baixada (the metropolitan area of Rio de Janeiro), Brazil (

Indexed as

HIV InfectionsPre-Exposure ProphylaxisTransgender PersonsAdolescentAdultBrazilFemaleHomosexuality, MaleHumansMaleSexual PartnersYoung AdultBrazilHIVtransgendertrans womenYouth

Identifiers

PMID33191759
PMCPMC8121889
OpenAlexW3099700070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.